Development and validation of rapid molecular diagnostic test for nCoV19

Objective

Rapid development of a molecular diagnostic test for Corona virus nCoV19 for near patient testing

Fields of science

• medical and health sciences › health sciences › infectious disease › RNA virus › coronavirus

Programme(s)

• H2020-EU.3.1.3. - Treating and managing disease

Topic(s)

• SC1-PHE-CORONAVIRUS-2020 - Advancing knowledge for the clinical and public health response to the 2019-nCoV epidemic

Call for proposal

H2020-SC1-PHE-CORONAVIRUS-2020
See other projects for this call

Funding Scheme

RIA - Research and Innovation action

Coordinator

HIBERGENE DIAGNOSTICS LIMITED

Address

21 Palmerstown Gardens, Rathmines
DUBLIN 6 Dublin
Ireland

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

EU contribution

€ 643 796,25

Participants (3)

THE QUEEN'S UNIVERSITY OF BELFAST

United Kingdom

EU contribution

€ 36 012,50

Address

University Road Lanyon Building
BT7 1NN Belfast

Activity type

Higher or Secondary Education Establishments

IRCCS OSPEDALE POLICLINICO SAN MARTINO

Italy

EU contribution

€ 61 875

Address

Largo Rosanna Benzi 10
16132 Genova

Activity type

Research Organisations

SHENZHEN MEDCAPTAIN MEDICAL TECHNOLOGY

China

EU contribution

€ 189 921

Address

5158 West Shahe Road 12Th Floor Baiwang Research Bulling 1 Xili Nanshan
518055 Shenzhen

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)